Kawachi Pharmaceutical Co., Ltd. - Annual Securities Report for the 59th Fiscal Period (March 16, 2025 – March 15, 2026)
NQ Score
66/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Kawachi Pharmaceutical Co., Ltd. has submitted its Annual Securities Report for the 59th fiscal period (March 16, 2025 to March 15, 2026) on June 10, 2026. This report provides official disclosures on financial performance, business results, and future strategies.
AI Analysis
Frequently Asked Questions
- Q: What does Kawachi Pharmaceutical's 59th fiscal period securities report include?
- A: It includes detailed financial and management information such as business performance, financial position, management policies, risk factors, and executive compensation.
- Q: Who benefits from the securities report filing?
- A: Investors, analysts, business partners, and employees—all stakeholders interested in corporate transparency and future outlook.
- Q: What is Kawachi Pharmaceutical's securities code?
- A: The securities code is 26640, listed on the Tokyo Stock Exchange Mothers market.
- Q: Where can the securities report be accessed?
- A: It is publicly available on EDINET, Japan's electronic disclosure system, free for anyone to view or download.
- Q: What business does Kawachi Pharmaceutical operate?
- A: It operates drugstores selling pharmaceuticals, health products, cosmetics, and daily goods, with a focus on community-based healthcare services.